Crystal Structure of 426cOD in Complex with VRC01 Fab

1-Gaussian fit: Grosse-Kunstleve RW, Sauter NK, Adams PD: Newsletter of the IUCr Commission on Crystallographic Computing 2004, 3, 22-31.

2-Gaussian fit: Grosse-Kunstleve RW, Sauter NK, Adams PD: Newsletter of the IUCr Commission on Crystallographic Computing 2004, 3, 22-31.

N-acetyl-beta-D-glucosamine; 2-acetamido-2-deoxy-beta-D-glucose; 2-acetamido-2-deoxy-D-glucose; 2-acetamido-2-deoxy-glucose; N-ACETYL-D-GLUCOSAMINE

HIV-1 VRC01 Germline-Targeting Immunogens Select Distinct Epitope-Specific B Cell Receptors.

18.425% PEG 3350, 11.011% 2-Methyl-2,4-pentanediol, 0.22M Lithium Sulfate, 0.11M Imidazole pH 6.5

National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)

Size exclusion chromatography was used to further purify the complex.

VRC01 Heavy Chain, VRC01 Light Chain, 426cOD

HIV, 426c, Outer Domain, VRC01, 426cOD, FAB, CD4, antibody, immunogen, IMMUNE SYSTEM, IMMUNE SYSTEM-VIRAL PROTEIN complex